The Regulatory Challenge of Electronic Cigarettes

Benowitz, Neal L.; Goniewicz, Maciej Ł.

doi:10.1001/jama.2013.109501

Cited by 157 publications

(127 citation statements)

References 9 publications

(9 reference statements)

Supporting

Mentioning

122

Contrasting

Unclassified

Order By: Relevance

“…Replacement cartridges are also available in a variety of flavors (Cobb, Brookover, & Cobb, 2013;Wollscheid & Kremzner, 2009). E-cigarettes have been marketed to tobacco smokers as a cessation aid (Food and Drug Administration, 2013) and for use in places where smoking is restricted (Benowitz & Goniewicz, 2013;Henningfield & Zaatari, 2010;Richardson, Ganz, Stalgaitis, Abrams, & Vallone, 2013). Manufacturers claim e-cigarettes are more cost-effective and socially acceptable compared with conventional cigarettes (Cobb et al, 2013;Pozin, 2013).…”

Section: Discussionmentioning

confidence: 99%

E-cigarette Availability and Promotion Among Retail Outlets Near College Campuses in Two Southeastern States

Wagoner¹,

Song²,

Egan³

et al. 2014

Nicotine &Amp; Tobacco Research

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

E-cigarette Availability and Promotion Among Retail Outlets Near College Campuses in Two Southeastern States

Wagoner¹,

Song²,

Egan³

et al. 2014

Nicotine &Amp; Tobacco Research

View full text Add to dashboard Cite

show abstract

“…Unlike combustible cigarettes, however, ENDS are not yet regulated under the FDA tobacco regulatory authority. As a result, there is a lack of mandatory manufacturing standards for ENDS, and few quality controls are in place (20). The FDA recently released a proposal (21) to extend its regulatory authority over ENDS.…”

Section: Current Regulation Of Endsmentioning

confidence: 99%

Electronic Nicotine Delivery Systems: A Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology

Brandon

Goniewicz

Hanna

et al. 2015

Clinical Cancer Research

Self Cite

View full text Add to dashboard Cite

Combustible tobacco use remains the number one preventable cause of disease, disability, and death in the United States. Electronic nicotine delivery systems (ENDS), which include ecigarettes, are devices capable of delivering nicotine in an aerosolized form. ENDS use by both adults and youth has increased rapidly, and some have advocated these products could serve as harm-reduction devices and smoking cessation aids. ENDS may be beneficial if they reduce smoking rates or prevent or reduce the known adverse health effects of smoking. However, ENDS may also be harmful, particularly to youth, if they increase the likelihood that nonsmokers or formers smokers will use combustible tobacco products or if they discourage smokers from quitting. The American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO) recognize the potential ENDS have to alter patterns of tobacco use and affect the public's health; however, definitive data are lacking. AACR and ASCO recommend additional research on these devices, including assessing the health impacts of ENDS, understanding patterns of ENDS use, and determining what role ENDS have in cessation. Key policy recommendations include supporting federal, state, and local regulation of ENDS; requiring manufacturers to register with the FDA and report all product ingredients, requiring childproof caps on ENDS liquids, and including warning labels on products and their advertisements; prohibiting youth-oriented marketing and sales; prohibiting child-friendly ENDS flavors; and prohibiting ENDS use in places where cigarette smoking is prohibited.

show abstract

“…Prior research has shown that currently most use of e-cigarettes is driven by a desire to quit cigarettes or to have a healthier alternative to cigarettes. 7,9 However, e-cigarettes, which are currently unregulated with very minimal safety or efficacy data, 65,66 were also rated as less risky than tested and regulated NRT. This may be related to perceived side effects from NRT, as suggested by reports here that NRT leads to more negative physical effects than e-cigarettes and findings that these two expectancies were correlated.…”

Section: E-cigarettes Versus Nicotine Replacement Therapiesmentioning

confidence: 99%

Expectancies for Cigarettes, E-Cigarettes, and Nicotine Replacement Therapies Among E-Cigarette Users (aka Vapers)

Harrell

Marquinez

Correa

et al. 2014

Nicotine &Amp; Tobacco Research

View full text Add to dashboard Cite

The Regulatory Challenge of Electronic Cigarettes

Cited by 157 publications

References 9 publications

E-cigarette Availability and Promotion Among Retail Outlets Near College Campuses in Two Southeastern States

E-cigarette Availability and Promotion Among Retail Outlets Near College Campuses in Two Southeastern States

Electronic Nicotine Delivery Systems: A Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology

Expectancies for Cigarettes, E-Cigarettes, and Nicotine Replacement Therapies Among E-Cigarette Users (aka Vapers)

Contact Info

Product

Resources

About